ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      68,122.09
      0.59%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Fusion Pharmaceuticals Inc (FUSN)

      7. Fusion Pharmaceuticals Inc (FUSN) News

      FUSN

      Fusion Pharmaceuticals (FUSN)

      Fusion Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FUSN
      DateTimeSourceHeadlineSymbolCompany
      05/31/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/31/20244:05PMPR Newswire (US)Fusion Pharmaceuticals Receives Final Court Order Approving ArrangementNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/31/20244:05PMPR Newswire (Canada)Fusion Pharmaceuticals Receives Final Court Order Approving ArrangementNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/29/20244:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/29/20244:05PMPR Newswire (Canada)Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZenecaNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/29/20244:05PMPR Newswire (US)Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZenecaNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/10/20244:15PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/10/20247:54AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/09/20244:14PMPR Newswire (US)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/09/20244:14PMPR Newswire (Canada)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/07/20248:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FUSNFusion Pharmaceuticals Inc
      05/07/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/07/20247:00AMPR Newswire (US)Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
      05/07/20247:00AMPR Newswire (Canada)Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
      04/26/20241:56PMPR Newswire (US)Kuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to Contact Law FirmNASDAQ:FUSNFusion Pharmaceuticals Inc
      04/25/20244:34PMPR Newswire (US)Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim OrderNASDAQ:FUSNFusion Pharmaceuticals Inc
      04/25/20244:34PMPR Newswire (Canada)Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim OrderNASDAQ:FUSNFusion Pharmaceuticals Inc
      04/09/20244:05PMPR Newswire (US)Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024NASDAQ:FUSNFusion Pharmaceuticals Inc
      04/09/20244:05PMPR Newswire (Canada)Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024NASDAQ:FUSNFusion Pharmaceuticals Inc
      03/20/20244:10PMPR Newswire (US)Kuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to Contact Law FirmNASDAQ:FUSNFusion Pharmaceuticals Inc
      03/20/20244:05PMPR Newswire (Canada)Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
      03/20/20244:05PMPR Newswire (US)Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program UpdatesNASDAQ:FUSNFusion Pharmaceuticals Inc
      03/19/20243:00AMPR Newswire (US)Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
      03/19/20243:00AMPR Newswire (Canada)Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
      03/06/20247:45AMPR Newswire (US)Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FUSNFusion Pharmaceuticals Inc
      03/06/20247:45AMPR Newswire (Canada)Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FUSNFusion Pharmaceuticals Inc
      03/05/20244:43PMPR Newswire (Canada)Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual MeetingNASDAQ:FUSNFusion Pharmaceuticals Inc
      03/05/20244:43PMPR Newswire (US)Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual MeetingNASDAQ:FUSNFusion Pharmaceuticals Inc
      02/26/20247:45AMPR Newswire (Canada)Fusion Pharmaceuticals to Present at Upcoming March Investor ConferencesNASDAQ:FUSNFusion Pharmaceuticals Inc
      02/26/20247:45AMPR Newswire (US)Fusion Pharmaceuticals to Present at Upcoming March Investor ConferencesNASDAQ:FUSNFusion Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:FUSN